Evidence map›Paper›PMID 28146081›Full record

ReviewToxins2017

p-Cresyl Sulfate.

Tessa Gryp, Raymond Vanholder, Mario Vaneechoutte, Griet Glorieux

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in Toxins, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 249 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
249citing papers in PubMed, 3 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03770611 naunknown statusnot on this mapstarted 2019, after this paper: background citation

Effect of a Nutritional Supplement of Probiotics and/or Prebiotics vs Placebo on Serum Concentrations of Uremic Toxins and Inflammatory Cytokines in Automated Peritoneal Dialysis Patients.

TypeinterventionalSponsorUnidad de Investigacion Medica en Enfermedades RenalesRan2019 to 2020Enrolled112ConditionsEnd Stage Renal Failure on DialysisArmsProbiotic, Prebiotic, Symbiotic, Placebo
NCT04554498 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Toxins Removal and Inflammatory State modulAtion During Online Hemodiafiltration: Comparison of Two Different Dialyzers

TypeinterventionalSponsorIRCCS Azienda Ospedaliero-Universitaria di BolognaRan2022 to 2024Enrolled16ConditionsHemodialysis Complication, Inflammation, Uremic, ToxemiaArms1) high flux hemodiafiltration thrice -weekly during a 24 month follow-up
3 · Its place in the literature

Who cites it

249 citing papers in PubMed, 3 syntheses or guidelines pooled it, 395 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

189 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tessa GrypDepartment of Internal Medicine, Nephrology Division, Ghent University Hospital, 9000 Ghent, Belgium. tessa.gryp@ugent.be.
Raymond VanholderDepartment of Internal Medicine, Nephrology Division, Ghent University Hospital, 9000 Ghent, Belgium. raymond.vanholder@ugent.be.
Mario VaneechoutteLaboratory for Bacteriology Research, Department of Clinical Chemistry, Microbiology & Immunology, Ghent University, 9000 Ghent, Belgium. mario.vaneechoutte@ugent.be.
Griet GlorieuxDepartment of Internal Medicine, Nephrology Division, Ghent University Hospital, 9000 Ghent, Belgium. griet.glorieux@ugent.be.
Ghent University Hospital · BEGhent University · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

If chronic kidney disease (CKD) is associated with an impairment of kidney function, several uremic solutes are retained. Some of these exert toxic effects, which are called uremic toxins.

Indexed as

Gastrointestinal MicrobiomeAnimalsBacteriaColonCresolsDietary ProteinsDysbiosisFermentationHumansKidneyPrognosisProtein BindingRenal Insufficiency, ChronicRenal Replacement TherapyRisk FactorsSulfuric Acid Esters4-cresol sulfateCresolsDietary ProteinsSulfuric Acid Esterschronic kidney diseaseintestinal microbiotap-cresyl sulfate

Identifiers

PMID28146081
PMCPMC5331431
OpenAlexW2580278050

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.